Diligence memo · auto-generated · as of July 2, 2026
TMRW Life Sciences, Inc.
TMRW Life Sciences, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
TMRW Life Sciences, Inc. operates in Other Health Care, based in NEW YORK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
TMRW Life Sciences, Inc. has raised $185M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $100M on 2021-06-30.
Most recent recorded round closed around 2024-06-28.
Valuation (modeled)modeled
Provath models TMRW Life Sciences, Inc. at approximately $284M (range $150M–$395M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.24× the median modeled value of Series D+ Other Health Care companies in 2022–2024 (17 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 2.0 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 3.6× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 98% of Other Health Care peers (5377 compared).
Modeled value ranks above 90% of those peers.
Closest niche peers: United Digestive Holdings, LLC, DispatchHealth Holdings, Inc., Zimmer Biomet Holdings, Inc., Main Street Rural, Inc., Richmond Buyer L.P..
Peoplefiled
16 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.